Sirolimus-eluting Stents With Biodegradable Polymer Versus an Everolimus-eluting Stents
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 2119 participants.
Also called NCT01443104
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 2,119 participants
- Registry
-
NCT01443104
-
- Main results
- Ultrathin strut biodegradable polymer sirolimus-eluting stent versus durable polymer everolimus-eluting stent for percutaneous coronary revascularisation (BIOSCIENCE): a randomised, single-blind, non-inferiority trial
- Other papers using this trial's data
- Biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents for primary percutaneous coronary revascularisation of acute myocardial infarction
- Clinical outcomes according to diabetic status in patients treated with biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents: prespecified subgroup analysis of the BIOSCIENCE trial
- Five-Year Outcomes With Biodegradable-Polymer Sirolimus-Eluting Stents Versus Durable-Polymer Everolimus-Eluting Stents in Patients With Acute Coronary Syndrome: A Subgroup Analysis of the BIOSCIENCE Trial
- Five-Year Outcomes in Patients With Diabetes Mellitus Treated With Biodegradable Polymer Sirolimus-Eluting Stents Versus Durable Polymer Everolimus-Eluting Stents
- Long-Term Effect of Ultrathin-Strut Versus Thin-Strut Drug-Eluting Stents in Patients With Small Vessel Coronary Artery Disease Undergoing Percutaneous Coronary Intervention: A Subgroup Analysis of the BIOSCIENCE Randomized Trial
- Ultrathin Strut Biodegradable Polymer Sirolimus-Eluting Stent Versus Durable-Polymer Everolimus-Eluting Stent for Percutaneous Coronary Revascularization: 2-Year Results of the BIOSCIENCE Trial
- Ultrathin-strut, biodegradable-polymer, sirolimus-eluting stents versus thin-strut, durable-polymer, everolimus-eluting stents for percutaneous coronary revascularisation: 5-year outcomes of the BIOSCIENCE randomised trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Switzerland
- Registry status
- Completed
Technical summary
Registry record NCT01443104. Randomized; no masking; primary purpose treatment. Start 2012-02 (actual); primary completion 2014-06 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Sirolimus-eluting Stents With Biodegradable Polymer Versus an Everolimus-eluting Stents
- Condition
- Coronary Artery Disease
- Condition
- Angina Pectoris
- Condition
- Myocardial Infarction
- Intervention (Device)
- Sirolimus-eluting stent with a bioresorbable polymer (Orsiro)
- Intervention (Device)
- Everolimus-eluting stent with a durable polymer
- Lead sponsor
- Insel Gruppe AG, University Hospital Bern
- Collaborator
- Biotronik AG
- Collaborator
- University of Bern
Record details
- Record id
cardio:ct-nct01443104- Content hash
25319ae6ac114863e99a4759860f15aa967cf1c99ff846d64157bf008ffcf47a